Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Polten

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancers|January 8, 2023
Towards Novel Gene and Cell Therapy Approaches for Cervical CancerRobert Polten, Ivana Kutle, Jens Hachenberg, et al.
Cancers|May 13, 2023
Tumor Organoid and Spheroid Models for Cervical CancerIvana Kutle, Robert Polten, Jens Hachenberg, et al.
Oncoimmunology|September 17, 2025
Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblastsRobert Polten, Ivana Kutle, Jan Lennart Stalp, et al.
Frontiers in Immunology|March 10, 2025
Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancerIvana Kutle, Robert Polten, Jan Lennart Stalp, et al.
Frontiers in Immunology|January 9, 2025
Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancerIvana Kutle, Robert Polten, Jan Lennart Stalp, et al.
International Journal of Molecular Sciences|April 17, 2025
Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical CarcinomaInken Flörkemeier, Hannah L Hotze, Anna Lena Heyne, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancers|January 8, 2023
Towards Novel Gene and Cell Therapy Approaches for Cervical CancerRobert Polten, Ivana Kutle, Jens Hachenberg, et al.
Cancers|May 13, 2023
Tumor Organoid and Spheroid Models for Cervical CancerIvana Kutle, Robert Polten, Jens Hachenberg, et al.
Oncoimmunology|September 17, 2025
Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblastsRobert Polten, Ivana Kutle, Jan Lennart Stalp, et al.
Frontiers in Immunology|March 10, 2025
Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancerIvana Kutle, Robert Polten, Jan Lennart Stalp, et al.
Frontiers in Immunology|January 9, 2025
Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancerIvana Kutle, Robert Polten, Jan Lennart Stalp, et al.
International Journal of Molecular Sciences|April 17, 2025
Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical CarcinomaInken Flörkemeier, Hannah L Hotze, Anna Lena Heyne, et al.
Pageof 1